Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA).

Clinical cardiology·2016
Same author

Glutathione (GSH) and the GSH synthesis gene Gclm modulate plasma redox and vascular responses to acute diesel exhaust inhalation in mice.

Inhalation toxicology·2013
Same author

T- and L-type voltage-gated calcium channels: their role in diabetic bladder dysfunction.

Neurourology and urodynamics·2013
Same author

Genetics of erectile dysfunction.

The Journal of urology·2012
Same author

Common pitfalls in some of the experimental studies in erectile function and dysfunction: a consensus article.

The journal of sexual medicine·2012
Same author

Glutathione (GSH) and the GSH synthesis gene Gclm modulate vascular reactivity in mice.

Free radical biology & medicine·2012

Related Experiment Videos

Review type 2 diabetes mellitus and erectile dysfunction.

Josephine Hidalgo-Tamola1, Kanchan Chitaley1

  • 1University of Washington-Department of Urology, Seattle, Washington, WA, USA.

The Journal of Sexual Medicine
|December 11, 2008
PubMed
Summary

Type 2 diabetes (T2DM) significantly contributes to erectile dysfunction (ED) through complex mechanisms. Understanding these factors is crucial for developing targeted therapies to improve sexual health in diabetic patients.

Related Experiment Videos

Area of Science:

  • Endocrinology
  • Urology
  • Diabetology

Background:

  • Diabetes Mellitus (DM) is a primary risk factor for Erectile Dysfunction (ED).
  • Most diabetic ED cases involve Type 2 Diabetes Mellitus (T2DM), yet research often uses Type 1 diabetes models.
  • Recent studies highlight key factors specific to T2DM-associated ED.

Purpose of the Study:

  • To review and compile the underlying mechanisms of T2DM-associated ED.
  • To synthesize findings from both clinical and basic science research on T2DM ED.

Main Methods:

  • Extensive literature search of clinical and basic science studies.
  • Utilized PUBMED database for study retrieval.
  • Focused on mechanisms underlying T2DM and their impact on ED.

Main Results:

  • T2DM-induced ED is multifactorial, often causing treatment resistance.
  • Hyperglycemia and hypogonadism in T2DM contribute to impaired vasodilatory signaling.
  • Key pathological changes include smooth muscle cell hypercontractility and veno-occlusive disorder.

Conclusions:

  • Understanding the diverse causes of ED in T2DM is essential.
  • Targeted therapeutic strategies can be developed based on specific mechanisms.
  • Improved erectile function may be achievable through tailored treatments for T2DM patients.